T
Thierry H. Le Jemtel
Researcher at Tulane University
Publications - 117
Citations - 3477
Thierry H. Le Jemtel is an academic researcher from Tulane University. The author has contributed to research in topics: Heart failure & Heart failure with preserved ejection fraction. The author has an hindex of 24, co-authored 105 publications receiving 3119 citations. Previous affiliations of Thierry H. Le Jemtel include Columbia University & Yeshiva University.
Papers
More filters
Journal ArticleDOI
Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction
Christian Valina,Kai Pinkernell,Yao-Hua Song,Xiaowen Bai,Sanga Sadat,Richard J. Campeau,Thierry H. Le Jemtel,Eckhard Alt,Eckhard Alt +8 more
TL;DR: This is the first study to show that not only bone marrow-derived cells but also ADSCs engrafted in the infarct region 4 weeks after intracoronary cell transplantation and improved cardiac function and perfusion via angiogenesis.
Journal ArticleDOI
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction ☆: Results of the New York heart failure registry
Marc Klapholz,Matthew S. Maurer,April M. Lowe,Frank C. Messineo,Jay S. Meisner,Judith E. Mitchell,Jill Kalman,Robert A. Phillips,Richard M. Steingart,Edward J. Brown,Robert Berkowitz,Robert Moskowitz,Anita Soni,Donna Mancini,Rachel Bijou,Khashayar Sehhat,Nikita Varshneya,Marrick L. Kukin,Stuart D. Katz,Lynn A. Sleeper,Thierry H. Le Jemtel +20 more
TL;DR: Patients hospitalized for heart failure with a normal ejection fraction are most often chronically incapacitated elderly women with a history of hypertension and increased LV mass, and reasons for clinical decompensation are identified in only one-half of patients.
Journal ArticleDOI
Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure
TL;DR: A large body of data indicates that patients with COPD tolerate well selective beta-blockade that should not be denied to CHF patients with concomitant COPD, which deprives patients with CHF due to LV systolic dysfunction of the most beneficial pharmacologic intervention.
Journal ArticleDOI
Vascular Inflammation in Obesity and Sleep Apnea
Sanja Jelic,David J. Lederer,Tessa Adams,Margherita Padeletti,Paolo C. Colombo,Thierry H. Le Jemtel +5 more
TL;DR: Untreated OSA rather than obesity is a major determinant of vascular endothelial dysfunction, inflammation, and elevated oxidative stress in obese patients.
Journal ArticleDOI
Maximally Recommended Doses of Angiotensin-Converting Enzyme (ACE) Inhibitors Do Not Completely Prevent ACE-Mediated Formation of Angiotensin II in Chronic Heart Failure
Ulrich P. Jorde,Pierre Vladimir Ennezat,Jay Lisker,Vanarani Suryadevara,Jason Infeld,Sonja Cukon,Adam Hammer,Edmund H. Sonnenblick,Thierry H. Le Jemtel +8 more
TL;DR: In this article, the level of ACE inhibition was assessed by the pressor response to angiotensin (Ang) I in patients who had been treated with recommended doses of ACE inhibitors.